A course of 4 treatments, spaced by 2-4 weeks. Each session takes about 15-20 minutes.
- The Patented Optimal Pulse Technology uses precise, intense broad-spectrum light to address the inflammation – one of the key underlining factors in dry eye disease due to Meibomian Gland Dysfunction (MGD).
Backed by numerous clinical studies and is first and only IPL FDA approved for Dry Eye Management
Reduces inflammatory mediators.
Destroys the abnormal blood vessels that perpetuate inflammation.
Improves tear breakup time. Significantly boost tear break-up time and decrease osmolarity.
Restores Meibomian gland functionality.
Decreases the population of Demodex mites, which stimulate infection and boost the bacterial load on eyelids.